Stemgent Obtains $11,299,993 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    One Kendall Square B6201 Cambridge, MA 02139
  • Company Description
    Stemgent advances stem cell science by providing proprietary reagents and tools developed and proven for reproducibility by some of the world’s leading stem cell scientists.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.